These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia]. Lengfelder E; Schultheis B; Büchner T; Hehlmann R Dtsch Med Wochenschr; 2007 Feb; 132(7):330-6. PubMed ID: 17286223 [No Abstract] [Full Text] [Related]
3. Advances in management of acute promyelocytic leukemia with arsenic trioxide. Ma J Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904 [No Abstract] [Full Text] [Related]
4. Clinical usefulness of arsenic trioxide in the treatment of acute promyelocytic leukemia. Lo Coco F Haematologica; 2002 May; 87(5):452-3. PubMed ID: 12010655 [No Abstract] [Full Text] [Related]
5. [Arsenic trioxide as a therapeutic agent in APL]. Emi N Nihon Rinsho; 2007 Jan; 65 Suppl 1():724-8. PubMed ID: 17474483 [No Abstract] [Full Text] [Related]
6. Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies. Tallman MS Blood Rev; 2001 Sep; 15(3):133-42. PubMed ID: 11735161 [No Abstract] [Full Text] [Related]
7. Comparing two arsenic trioxide administration methods in APL therapy. Zhou J; Meng R; Yang BF Chin Med J (Engl); 2004 Sep; 117(9):1411-3. PubMed ID: 15377438 [No Abstract] [Full Text] [Related]
9. Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia. Ammatuna E; Cavaliere A; Divona M; Amadori S; Scambia G; Lo-Coco F Br J Haematol; 2009 Aug; 146(3):341. PubMed ID: 19545283 [No Abstract] [Full Text] [Related]
10. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement. Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415 [TBL] [Abstract][Full Text] [Related]
11. Hyperleukocytosis from arsenic trioxide. Levy M; Wofford MM; Powell BL; McLean TW Pediatr Blood Cancer; 2008 Jun; 50(6):1265-7. PubMed ID: 18300308 [TBL] [Abstract][Full Text] [Related]
12. Two cases of monocular visual loss during oral arsenic trioxide therapy of acute promyelocytic leukemia. Au WY; Hon C; Yau K; Lai WW; Fong BM; Tam S; Kwong YL Am J Hematol; 2009 Oct; 84(10):699. PubMed ID: 19705432 [No Abstract] [Full Text] [Related]
13. Clinical efficacy of arsenic trioxide in a patient with acute promyelocytic leukemia with recurrent central nervous system involvement. Zappasodi P; Rossi M; Ambaglio I; Bernasconi P; Corso A; Lazzarino M; Castagnola C Ann Hematol; 2011 May; 90(5):595-7. PubMed ID: 20721555 [No Abstract] [Full Text] [Related]
14. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia. Sui M; Zhang Z; Zhou J Chin Med J (Engl); 2014; 127(19):3503-6. PubMed ID: 25269921 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid. Tong H; Li K; Mei C; Wang H; Chen Z; Jin J Ann Hematol; 2011 Dec; 90(12):1493-4. PubMed ID: 21431323 [No Abstract] [Full Text] [Related]
16. Real-time quantification of the multidrug resistance-1 gene expression in relapsed acute promyelocytic leukemia treated with arsenic trioxide. Au WY; Chim CS; Wai Lie AK; Pang A; Kwong YL Haematologica; 2002 Oct; 87(10):1109-11. PubMed ID: 12368167 [No Abstract] [Full Text] [Related]